Industry NewsFerrer announces first patient enrollment of FNP122 in ADORE Phase III trial for ALS treatment
Industry NewsResearchers discover a new tool that uses high-powered lasers to help improve cancer treatment
Industry NewsNew sub-analyses further support consistency of Farxiga’s cardiorenal and mortality benefits
Product NewsRoche launches comprehensive genomic profiling kit to expand access to personalized cancer research
Industry NewsRoche’s VENTANA PD-L1 Assay receives FDA approval as a companion diagnostic to identify lung cancer patients eligible for Tecentriq (atezolizumab)